FDA.reportPublic FDA data

rimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral Tablet

RxCUI
2282313
RxNorm name
rimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral Tablet
Display name
rimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral Tablet
Full name
rimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NURTEC ODTRIMEGEPANT SULFATEPfizer Laboratories Div Pfizer Inc9ef08e09-1098-35cc-e053-2a95a90a3e1d2026-06-04Warnings, Adverse reactionsExact identifier
rxcui: 2282313
NURTEC ODTRIMEGEPANT SULFATESportpharm LLC86ef19d2-d6dc-4ac1-a793-dc549cc6bb9b2026-04-24Warnings, Adverse reactionsExact identifier
rxcui: 2282313

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9ef08e09-1098-35cc-e053-2a95a90a3e1drimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral TabletSY31These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260421
9ef08e09-1098-35cc-e053-2a95a90a3e1drimegepant 75 MG Disintegrating Oral TabletSCD31These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260421
9ef08e09-1098-35cc-e053-2a95a90a3e1drimegepant 75 MG Disintegrating Oral TabletPSN31These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260421
86ef19d2-d6dc-4ac1-a793-dc549cc6bb9brimegepant 75 MG Disintegrating Oral TabletSCD2These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260424
86ef19d2-d6dc-4ac1-a793-dc549cc6bb9brimegepant 75 MG Disintegrating Oral TabletPSN2These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260424
86ef19d2-d6dc-4ac1-a793-dc549cc6bb9brimegepant 75 MG (as rimegepant sulfate 85.65 MG) Disintegrating Oral TabletSY2These highlights do not include all the information needed to use NURTEC ® ODT safely and effectively. See full prescribing information for NURTEC ODT. NURTEC ODT (rimegepant) orally disintegrating tablets, for sublingual or oral use Initial U.S. Approval: 202020260424